Skip to content

Incidence of Non Receptive Endometrium in Obese Women

Incidence of Not Receptive Endometrium During the Window of Implantation as Body Mass Index by Testing ERA.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02205866
Enrollment
183
Registered
2014-07-31
Start date
2014-08-31
Completion date
2017-07-31
Last updated
2019-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Brief summary

This study evaluates the incidence of Non Receptive endometrium in obese infertile women compared to infertile normal weight women using Endometrial Receptivity Array (ERA) test, containing 238 genes, identifying the receptivity status of an endometrial sample and diagnosing the patient's Window of Implantation, regardless of the histological appearance of the sample. An endometrial biopsy is collected from the uterine fundus, either in a natural cycle or in a hormonal replacement therapy (HRT) cycle and the test is performed.

Interventions

OTHEREndometrial Receptivity Array analysis of endometrial biopsy

A biopsy of endometrium is peformed and Endometrial Receptivity Array analysis is carried out, as well as analysis of fat distribution and risk factors of Metabolic Syndrome.

Sponsors

Instituto Valenciano de Infertilidad, IVI VALENCIA
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Infertile women: \> 1 year of regular unprotected intercourse without evidence of pregnancy. * Normal uterus by 2D/3D ultrasound scan and/or hysteroscopy * No endometriosis * Presence of both ovaries * \< 45 years old (in ovum donation, outcome parameters are not affected until this age in all the current published studies).

Exclusion criteria

* Hydrosalpinx * Stage 3-4 endometriosis diagnosed with ultrasound, laparoscopy/ laparotomy. * Implantation failure (≥ 4 pre-embryos of good quality transferred without pregnancy) * Recurrent pregnancy loss (≥ 2 pregnancies biochemical / clinical)

Design outcomes

Primary

MeasureTime frameDescription
Non Receptive Endometrium25 daysTo evaluate the incidence of Not Receptive endometrium in obese infertile women compared to infertile normal weight women using an adequate sample size.

Secondary

MeasureTime frameDescription
Distribution of fat and risk factors4 monthsCarry out a subanalysis concerning the distribution of central and peripheric fat and risk factors of metabolic syndrome including: Age (years); Height (m); Weight (kg) ; BMI (kg/m2); Waist (cm) ; Hip (cm); Index waist-hip ratio (WHR) waist (cm) / hip (cm); Blood pressure; insulinemia Fasting blood glucose (mmol / L); PTG ( tolerance oral glucose ) (mmol / L), Total cholesterol and fractions; Triglycerides Microalbuminuria; bA1C, HC-reactive protein.
Look for specific endometrial gene patterns.25 daysFind patterns of expression of specific genes in endometrial obese women: we will by analyzing the expression of 238 genes obtained after endometrial endometrial biopsy.
Evaluate the result of assisted reproduction treatment.12 monthsRelate if the displacement of the WOI induced by the obesity is clinically relevant after the personalized embryo transfer.

Countries

Spain, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026